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Abstract
Mechanisms governing peripheral CD4+ FOXP3+ regulatory T cells (Treg) survival and homeostasis are multiple suggesting
tight and complex regulation of regulatory T cells homeostasis. Some specific factors, such as TGF-b, interleukin-2 (IL-2) and
B7 costimulatory molecules have been identified as essentials for maintenance of the peripheral Treg compartment.
Conversely, Treg dependency upon classical T cell homeostatic factors such as IL-7 is still unclear. In this work, we formally
investigated the role of IL-7 in Treg homeostasis in vivo in murine models. We demonstrated that IL-7 availability regulated
the size of peripheral Treg cell pool and thus paralleled the impact of IL-7 on conventional T cell pool. Moreover, we showed
that IL-7 administration increased Treg cell numbers by inducing thymic-independent Treg peripheral expansion.
Importantly the impact of IL-7 on Treg expansion was detected whether conventional T cells were present or absent as IL-7
directly participates to the peripheral expansion of Treg after adoptive transfer into lymphopenic hosts. Our results
definitively identify IL-7 as a central factor contributing to Treg peripheral homeostasis, thus reassembling Treg to other T
cell subsets in respect of their need for IL-7 for their peripheral maintenance.
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Introduction
CD4
+ CD25
+ FOXP3
+ regulatory T cells are a population of
CD4 T cells crucial for the regulation of immune responses and in
preventing autoimmunity and chronic inflammation [1]. Mice and
humans genetically deficient in Treg cells as a result of mutations
in Foxp3, a critical transcription factor for Treg development and
function, typically present severe lympho-proliferation and
immune pathology [2–5]. Treg exert their major role in the
maintenance of immune-tolerance through several mechanisms
including secretion of inhibitory molecules, suppression of antigen-
presenting cells function, cytolysis and effector cells metabolic
disruption [6]. Despite the importance of the Treg compartment
for the maintenance of immune tolerance and the intensive
investigation focusing on Treg cell biology during the last few
years, uncertainties remain about the factors controlling peripheral
Treg survival and homeostasis. While Treg homeostasis appears to
rely on some subset specific factors such as TGF-b [7–9], IL-2
[10–13] and B7 costimulatory molecules [14,15], their dependen-
cy upon factors classically involved in conventional T cells
homeostasis such as IL-7 signaling still remains controversial. IL-
7 plays a critical role in T cell development and peripheral
homeostasis [16]. All major CD4 T cell subsets, including naı ¨ve,
memory and Th17 CD4 T cells, strictly rely on IL-7 for their
peripheral homeostasis [17–20]. The only important exception
seems to be represented by CD4
+ FOXP3
+ Treg which have been
reported to express low levels of the IL-7 receptor alpha chain
(CD127) [21–23]. Accordingly, peripheral Treg biology is believed
to be essentially independent of IL-7/IL-7Ra signaling [17,24–28]
although Bayer et al suggested that IL-7 could contribute to Treg
homeostasis when IL-2 signaling is disrupted [24]. However, we
and others have previously shown that in vitro IL-7 treatment
induces significant STAT5 phosphorylation in Tregs [26,29–31]
and that IL-7 is able to increase in vitro Treg survival [30,32,33].
These in vitro data revealing a potential role of IL-7 on Treg
homeostasis need to be substantiated by in vivo analysis. We first
considered Treg homeostasis in mice exhibiting altered IL-7
signaling pathway using IL-7Ra2/2, IL-72/2 or IL-7 Tg mice.
Regarding the increasing development of IL-7 based therapies we
also investigated how in vivo Treg homeostasis was affected
following IL-7 injection. We demonstrated that IL-7 availability
regulated the size of the peripheral Treg cell pool and that Treg
and Tconv were equally affected following IL-7 injection.
Moreover, we showed that IL-7 administration increased Treg
cell numbers by inducing a thymic-independent peripheral
expansion. Importantly the impact of IL-7 on Treg expansion
was detected whether conventional T cells were present or absent
as IL-7 directly participates to the peripheral expansion of Treg
after adoptive transfer into lymphopenic hosts. Collectively, our
data identify IL-7 as a central factor contributing to Treg
peripheral homeostasis. Such a conclusion has major implications
for the development of IL-7 based strategies to ameliorate
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immune pathology.
Results
IL-7 availability affects the size of the conventional and
regulatory T cell pools to a similar extent
To provide an exhaustive analysis of the influence of IL-7 on
Treg homeostasis in vivo, we first examined mice in which IL-7
signaling was genetically disrupted (IL-7Ra2/2 or IL-72/2)o r
increased (IL-7 Tg). Because IL-7 directly impacts thymic
cellularity, both thymic and peripheral Treg distribution and
cellularity were determined. In agreement with previous reports
[26,27], IL-7Ra2/2 mice display similar percentages of thymic
FOXP3
+ cells among single positive CD4 cells when compared to
normal C57Bl/6 mice (3.43%60.76% in IL-7Ra2/2 versus
3.33%60.24% in WT) while IL72/2 mice present slight though
statistically significant reduction in proportion of FOXP3
+ cells
among CD4 T cells (2.6260.23%, p 0.003) (Fig. 1A). Conversely,
significantly higher percentages of Treg were observed in thymi
from IL-7 Tg mice (5.1660.48%, p,0.0001) (Fig. 1A). Study of
absolute thymic T cell numbers revealed that the expected
reduction in FOXP3
2 CD4
+ single positive thymocytes in IL-
7Ra2/2 or IL-72/2 mice was associated to a proportional
reduction in the FOXP3
+ CD4
+ single positive compartment
(Fig. 1B). Accordingly IL-7 over-expressing mice presented higher
numbers of both FOXP3
2 and FOXP3
+ CD4
+ single positive
thymocytes. Collectively these data suggest that IL-7 signaling
similarly affects conventional T cells (Tconv) and Treg cell thymic
development. We then focused on splenocytes in order to evaluate
IL-7 contribution in controlling Treg cell peripheral cell numbers.
As already described, higher percentages of FOXP3
+ cells were
found among splenic CD4 T cells from IL-7Ra2/2 and IL-72/
2 mice when compared to control C57Bl/6 mice (Fig. 1A)
(27.18%64.23% in IL-7Ra2/2 and 28.26%60.99% in IL-72/
2 versus 14.09%61.09% in WT; p,0.0001). Such a difference is
presumably linked to impaired peripheral survival of conventional
naı ¨ve CD4 T cells in the absence of IL-7 signaling and suggests a
lower impact of IL-7 on Treg. Interestingly, IL-7 Tg mice
presented preserved proportion of splenic Treg cells among CD4
T cells (17%63.62%) (Fig. 1A). Analyzing T cells numbers, we
observed as expected that conventional CD4
+ FOXP3
2 T cell
numbers were significantly reduced in IL-7Ra2/2 and IL-72/2
mice (13.8-fold and 5.4-fold reduction respectively) while they
were present in higher numbers in IL-7 Tg mice (WT
7.5610
662.8610
6 vs IL-7 Tg 27.9610
665.0610
6,p ,0.0001)
(Fig. 1B). Accordingly, IL-7Ra2/2 and IL-72/2 mice presented
significantly reduced but yet substantial numbers of peripheral
Treg cells compared with their wild type counterparts (WT
1.2610
660.4610
6 vs IL-7Ra2/2 0.2610
660.1610
6 vs IL-72/
2 0.5610
660.1610
6), while IL-7 Tg mice presented a 4.7-fold
increase in Treg cell number (Fig. 1B). Interestingly the extent of
Treg number variation in spleen from KO or Tg mice reflected
the variation we observed in the conventional FOXP3
2 CD4 T
cell compartment. Due to the crucial role of IL-7 on thymic
development, these results do not allow drawing any conclusion on
the direct impact of IL-7 on peripheral T cell homeostasis.
Nevertheless, these results suggest that IL-7 similarly affects
conventional and regulatory T cell numbers by acting on thymic
development and/or peripheral homeostasis.
IL-7/aIL-7 complexes treatment induces both
conventional and regulatory T cells expansion
To better assess the peripheral role of IL-7, we determined the
effects of exogenous IL-7 treatment on Treg cells. C57Bl/6 mice
were injected with IL-7/aIL-7 complexes or PBS at d0, d2 and d4.
Such a treatment protocol has been reported to induce strong
peripheral expansion of conventional CD4 and CD8 T cells in
non-lymphopenic hosts [25]. Flow cytometry analysis at day 7
from the first injection revealed a slight but significant reduction in
the percentage of FOXP3
+ CD4 T cells in the lymph-nodes (NT
11.1%61.0% vs IL-7 9.2%61.1%, p=0.044) that was not
detected in the spleen (NT 10.8%61.4% vs IL-7 11.4%60.6%,
p=0.586) (Fig. 2A). When considering absolute numbers, IL-7
treatment increased both CD4
+ FOXP3
2 and FOXP3
+ cell
numbers (approximately 2 fold increase in both LN and SP)
(Fig. 2B). Similarly to the analysis in mice bearing disrupted or
increased IL-7 signaling (Fig. 1), conventional and regulatory T
cells thus appeared similarly affected by IL-7 injection treatment.
Theoretically, increase in peripheral T cell numbers results from
effects on peripheral proliferation, cell survival and/or thymic
production. Total and Treg thymic cellularity were not signifi-
cantly different in IL-7/aIL-7 treated animals compared to PBS
injected animals (data not shown). To exclude any potential
contribution of thymopoiesis on observed IL-7 effects, we
adoptively transferred CFSE stained CD4 T cells from CD45.1
mice into CD45.2 C57Bl/6 mice prior to IL-7 complexes
treatment. Use of CD45.1 and FOXP3 staining allowed us to
distinguish progeny of adoptively transferred cells from host cells
(Fig. 3A). At day 7, a two-fold expansion was observed in FOXP3
+
CD4
+ transferred CD45.1 Treg cells isolated from IL-7 complexes
treated mice when compared to PBS injected mice (Fig. 3B).
Collectively, these data demonstrate that IL-7 impacts peripheral
Treg homeostasis.
IL-7/aIL-7 complexes treatment affects the Treg
proliferative fraction
We next questioned whether IL-7 treatment affected Treg
proliferation as described for conventional T cells.
We examined Ki67 staining, which identifies proliferating cells,
in C57Bl/6 mice injected or not with IL-7/aIL-7 complexes. The
fraction of cycling conventional CD4 T cells was 4 fold increased
in lymph nodes reaching 22.3%63.3% of conventional T cells,
whereas the Treg proliferating fraction was slightly but signifi-
cantly affected (NT 15.5%62.1% vs IL-7 18.2%62.4%,
p=0.0344) (Fig. 4A). Similar observation was obtained when
analyzing splenic conventional T cells and Treg cells. We next
evaluated the contribution of peripheral cell proliferation in the
observed expansion of CD45.1 T cells transferred into C57Bl/6
mice, as described in Fig. 3. We analyzed the CFSE dilution
profile of adoptively transferred cells isolated from LN at day 7.
IL-7 complexes treatment induced an increase in the CFSElow
proliferating fraction in both conventional (NT 5.8%60.6% vs IL-
7 18.8%68.2%, p=0.0191) and Treg cell (NT 17.7%63.7% vs
IL-7 26.5%64.6%, p=0.0252) compartments (Fig. 4B). Similar
observation was obtained when splenic conventional and Treg
cells were analyzed. In accordance to data obtained with the Ki67
staining, increase in proliferation upon IL-7 treatment was more
important in Tconv than in Treg cell compartments. Collectively,
these results indicate that IL-7 therapy affects both conventional
and regulatory T cell numbers and acts at different extent on their
proliferation.
Il-7 Impacts Treg
PLoS ONE | www.plosone.org 2 May 2012 | Volume 7 | Issue 5 | e36596Figure 1. IL-7 signaling is involved in both thymic development and peripheral maintenance of Foxp3+ Treg. (A) Representative dot
plots of FOXP3 expressing cells gated on CD4
+ CD8
2 TCRb
+ thymocytes and splenic CD4
+ TCRb
+ cells from normal B6, IL-7Ra2/2, IL-72/2 and IL-7
Tg animals. Numbers in each dot plot indicate the relative percentages of FOXP3 cells among CD4
+ T cells for representative animal selected among 4
to 6 mice per group. (B) Absolute numbers of CD4
+ FOXP3
+ T cells from normal B6, IL-7Ra2/2, IL-72/2 and IL-7 Tg animals. Each point represents a
single mouse and mean values are indicated for each groups. Experiments were repeated independently twice with four to six mice per group; the
data shown are representative of one experiment. The degree of statistical significance (p values), relative to normal B6 numbers, is indicated.
doi:10.1371/journal.pone.0036596.g001
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lymphopenic hosts
Treg survival is highly dependent on IL-2 [12,13]. Increase in
Treg cellularity upon IL-7 treatment may reflect increased IL-2
production by the proliferating conventional/effector cells frac-
tion. To formally address the direct impact of IL-7 on Treg
biology, we used adoptive transfer into lymphopenic hosts, in
which Treg expansion could be observed in the absence of
potential IL-2 producing conventional T cells. We first transferred
purified CFSE labeled CD4
+ CD25
+ cells into IL-7 competent or
deficient empty hosts (Rag2/2 or Rag2/2 IL-72/2 mice)
(Fig. 5). Treg recovered from spleen of both groups were identified
by FOXP3 intracellular staining at day 1 and 6 (Fig. 5A).
Importantly, similar proportions of FOXP3
2 non Treg cells were
detected in the two groups of recipient mice suggesting similar
impact of potential contaminating effector T cells (Fig. 5B). We
first analyzed the CFSE dilution profile of injected Tregs in both
hosts. Higher proportion of dividing FOXP3
+ Tregs was evident in
IL-7 competent hosts compared to IL-7 deficient hosts (Fig. 5C).
However, number of division undergone by Tregs did not
significantly differ: most dividing Tregs have undergone more
than 7 divisions in both Rag2/2 and Rag2/2 IL-72/2
recipients. We next analyzed absolute Treg cell recovery from
recipients spleen. At day 1, Treg cell numbers recovered from
spleen were slightly but statistically different between IL-7 deficient
and IL-7 competent hosts. Such higher splenic homing in Rag2/
2 IL-72/2 recipients presumably reflects the absence of LN
structures in the absence of IL-7. Conversely, Treg cells numbers
recovered at day 6 were significantly higher in Rag2/2 hosts
compared to Rag2/2 IL-72/2 hosts (Fig. 5B). Notably, day 6
Treg recovery in IL-7 competent hosts was increased compared to
day 1, whereas Treg numbers recovered in IL-7 deficient hosts
were reduced compared to d1 values. In order to confirm our
results while excluding the potential bias induced by co-transfer of
contaminating conventional non-Treg FOXP3- cells, we adop-
tively transferred highly purified FACS sorted CD4
+ FOXP3GFP
+
cells (Fig. 5E) from mice in which a green fluorescent protein
(GFP) encoding sequence was introduced under the FOXP3
promoter (Fig. 5E). Even in these conditions, significantly higher
numbers of CD4
+ TCRb
+ FOXP3
+ Treg cells were recovered in
Rag2/2 hosts compared to Rag2/2 IL-72/2 hosts (Fig. 5F)
pointing to a direct effect of IL-7. In this setting where
contamination by non FOXP3 cells can be excluded, we detected
a small fraction of FOXP3 non expressing T cells at day 8. Down
regulation of FOXP3 expression by Treg has been previously
described following transfer into empty hosts [34–37]. We
questioned whether IL-7 availability may affect differently Treg
conversion and indirectly modulate Treg accumulation. We thus
determined the percentage of Treg conversion in both hosts. At
day 8, 93%62% of CD4
+ TCRb
+ cells recovered from Rag2/2
hosts still expressed FOXP3GFP, suggesting limited conversion to
effector FOXP3
2 non-Treg cells (Fig. 5G). Importantly, we did
not detect any significant differences in the percentage of
converted Tregs in the presence of absence of IL-7 suggesting
IL-7 did not crucially affected Treg conversion (7.17%62.19% in
Rag2/2 vs 5.53%62.45% in Rag2/2IL-72/2; p 0.6458).
Figure 2. IL-7 complexes treatment induced both conventional and regulatory T cell expansion. C57Bl/6 mice were i.p. injected with PBS
or IL-7/anti-IL-7 complexes (1 mg rmIL-7 plus 5 mg M25) three times at 2 day intervals. LN and SP cells were analyzed 7 days after the first injection. (A)
Representative dot plots of CD25 vs FOXP3 expression on CD4
+TCRb
+ cells recovered from PBS or IL-7 complexes treated mice. (B) Total number of
CD4
+TCRbFOXP3
2 conventional T cells (left panels) and CD4
+ TCRb FOXP3
+ regulatory T cells (right panels) from lymph nodes and spleen.
doi:10.1371/journal.pone.0036596.g002
Il-7 Impacts Treg
PLoS ONE | www.plosone.org 4 May 2012 | Volume 7 | Issue 5 | e36596Collectively, these data demonstrate that Treg expansion and
accumulation in lymphopenic settings is IL-7 dependent.
Discussion
All major CD4 T cell subsets, including naı ¨ve, memory and
Th17 CD4 T cells, strictly rely on IL-7 for their peripheral
homeostasis. The only important exception seems to be repre-
sented by CD4
+ FOXP3
+ Treg cells, which are believed to
essentially rely on other factors such as IL-2, TGF-b and
costimulatory molecules. Although several cc cytokines, including
IL-2, IL-4, IL-7, IL-15, IL-21, have been reported to increase
Treg survival in vitro [33], only IL-2 has been clearly established as
a major factor controlling Treg cell homeostasis in vivo [10–
13,38,39]. Several reports investigated the role of IL-7 on thymic
Treg development [24,26,27] and tried to extend the analysis to
the peripheral effects of IL-7. Using adoptive transfer of total CD4
T cells into irradiated Rag2/2 or Rag2/2 IL-72/2 mice,
Mazzuchelli et al, failed to detect any differences in Treg numbers
recovered concluding that IL-7 availability does not affect Treg
peripheral survival [26]. Unfortunately, total lymph-node cells
were transferred, impeding any conclusions on the direct effect of
IL-7 on Treg cells in this setting. The present study aimed to
further investigate the effects of IL-7 on the homeostasis of CD25
+
FOXP3
+ regulatory T cells. Importantly, we demonstrated that
IL-7 availability controls the size of both Tconv and Treg pools.
Mice in which IL-7 signaling was impaired presented a reduction
in Treg cell numbers similar to those observed in conventional T
cell numbers. Conversely, IL-7 Tg mice, in which IL-7 production
is constantly increased, showed an expansion of the Treg
compartment. However, one may question the relevance of
studies performed in mice exhibiting disruption of IL-7/IL-7R
signaling, which severely impact thymic differentiation and
peripheral T cell homeostasis. We next used a more relevant
model allowing us determining the impact of IL-7 on physiolog-
ically generated Treg. Using IL-7 injection protocol, we confirm
the impact of IL-7 on Treg homeostasis. IL-7 treatment in normal
mice induced an increase in conventional CD4 T cell numbers
that was strictly paralleled by an increase in Treg cell numbers.
Importantly demonstrating that IL-7 levels equally affect the size
of conventional and Treg subsets perfectly corroborate results
obtained in humans during clinical trials investigating the effects of
IL-7 therapy on immune-reconstitution in lymphopenic settings.
Indeed, three published reports analyzed the proportion of Treg
cells in peripheral blood from patients treated with IL-7 [40–42]
and detected either slight reduction or no difference in the
percentage of Treg cells among CD4 T cells after IL-7 treatment.
Because total CD4 T cell count increased in IL-7 treated patients,
essentially preserved Treg percentages indicate that Treg changes
in absolute numbers also paralleled those detected in conventional
CD4 T cells in human studies. We next aimed to determine the
mechanisms involved in IL-7 mediated effects on Treg pool.
Because the impact of IL-7 on conventional T cell proliferation
[43] and survival [44] has been extensively described, we aimed to
determine whether IL-7 influenced Treg homeostasis by similar
mechanisms. Interestingly, IL-7 differently impacted conventional
and regulatory T cell compartment: the fraction of proliferating T
cells were 3-fold increased in conventional T cells, but mildly
increased in Treg fraction in IL-7 treated C57Bl/6 mice. Although
significant, such low increases in Treg proliferative capacity is
unlikely to account for the highly significant increase in Treg
cellularity upon IL-7/aIL-7 complex treatment. These results thus
suggest IL-7 treatment is likely to increase Treg cell numbers in
the periphery by affecting both their survival and accumulation as
previously suggested [30,32,33] together with their proliferative
capacity. Because the fraction of proliferating conventional T cells
was significantly increased upon IL-7 treatment, we speculated
that the beneficial impact of IL-7 on Treg homeostasis essentially
rely on increased IL-2 availability due to the increased fraction of
activated/effector conventional T cells. Indeed, IL-7 is highly
heterogeneous in targets and mechanisms [16], favoring both
conventional T cell homeostasis and effector differentiation
[45,46]. To determine the impact of IL-7 on Tregs in the absence
of conventional T cells, we performed adoptive transfer of purified
Treg into Rag2/2 or Rag2/2 IL-72/2 mice. We showed that
Treg cells transferred into Rag-deficient mice lacking IL-7
proliferated and accumulated less than Treg transferred into IL-
7 competent Rag-deficient mice. To note, residual proliferation
was still present in the absence of IL-7 indicating that other factors
participate to the phenomenon. Although residual IL-2 production
by DCs or ‘‘exFOXP3’’ converted Treg cannot be formally
excluded [37,47], other cc cytokines may also impact Treg
peripheral homeostasis [33]. We thus demonstrated the direct
impact of IL-7 on Treg biology in the absence of conventional T
cells. However, we cannot exclude that the impact of IL-7 on Treg
homeostasis may combine both direct and indirect effects [48].
Figure 3. IL-7 induced expansion of both conventional and
regulatory T cells is thymic independent. CFSE labeled total CD4 T
cells from CD45.1 mice were transferred into CD45.2 C57Bl/6 hosts.
Mice were then treated with IL-7/anti-IL-7 complexes as in Fig. 2. (A)
Representative dot plots of CD45.1 vs FOXP3 expression on CD4
+ TCRb
cells recovered from lymph nodes and spleens of PBS or IL-7 complexes
treated mice. (B) Total numbers of adoptively transferred CD45.1
FOXP3
2 conventional T cells (left panels) and CD45.1 FOXP3
+ regulatory
T cells (right panels) from lymph nodes and spleen.
doi:10.1371/journal.pone.0036596.g003
Il-7 Impacts Treg
PLoS ONE | www.plosone.org 5 May 2012 | Volume 7 | Issue 5 | e36596In summary, our data establish a role for IL-7 in Treg
homeostasis, thus reassembling Treg to other T cell subsets in
respect of their need for IL-7 for their peripheral maintenance.
They indicate that IL-7 availability similarly affects both the
conventional and the regulatory T cell pool, maintaining their
proportions relatively unchanged. This balanced effect of IL-7 on
both the conventional and the regulatory T cell pool can be
important to prevent immune-pathology during both spontaneous
and therapeutic IL-7 induced immune reconstitution.
Materials and Methods
Ethics Statement
Mice were kept under specific pathogen free conditions in
accordance with institutional guidelines in compliance with
French and European animal welfare regulations (agreement B-
94-043-12, delivered by the French veterinary authorities). All
animal studies were approved by the ethics Committee of
University Paris Sud and protocols conducted were authorized
by French veterinary authorities (licence 94-440) in accordance
with French and European guidelines.
Mice
6 to 8 weeks old C57Bl/6 were purchased from Charles River
(Janvier). Mice deficient for Rag gene (Rag2/2) or for Rag and
IL-7 genes (Rag2/2 IL-72/2) were used as hosts for adoptive
transfer experiments. IL-7Ra2/2 mice were purchased from the
Jackson Laboratory. IL-72/2 and IL-7 transgenic (IL-7 Tg) mice
were kindly provided by Dr. Sophie Ezine. Foxp3-GFP mice were
Figure 4. IL-7 mildly impacts CD4+CD25+ Treg cells proliferative capacity. Unmanipulated C57Bl/6 mice (A) or C57Bl/6 mice transferred
with CFSE labeled total CD45.1 CD4 T cells (B) were i.p. injected with PBS or IL-7/anti-IL-7 complexes (1 mg rmIL-7 plus 5 mg M25) three times at 2 day
intervals. (A) Percentage of cells expressing the proliferation marker Ki67 in CD4
+ TCRb
+FOXP3
2 conventional T cells and CD4
+ TCRb FOXP3
+
regulatory T cells from LN (left panel) and spleen (right panel). Percentage of Ki67 positive cells were determined based on isotype control. Results
were pooled from 2 separate experiments, using three to four mice per group. (B) Representative CFSE profiles of CD45.1 Tconv and Treg isolated at
day 7 from PBS or IL-7 complexes treated mice. Experiments were repeated independently three times with two to four mice per group. Data shown
are representative of one experiment.
doi:10.1371/journal.pone.0036596.g004
Il-7 Impacts Treg
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PLoS ONE | www.plosone.org 7 May 2012 | Volume 7 | Issue 5 | e36596purchased from the Jackson Laboratory. All mice were kept under
specific pathogen free conditions and all experiments were
performed according to institutional guidelines of the European
Community.
Cell purification
Single cell suspensions were prepared from lymph nodes (pooled
inguinal, brachial, axillary and mesenteric) and spleens HBSS
containing 2% FCS (PAA Laboratories GmbH). For total CD4 T
cells transfer, CD4 T cells were isolated using BD magnetic beads
(Becton-Dickinson). For CD4+ CD25+ Treg adoptive transfer
experiments, CD4+ CD25+ cells were isolated by magnetic beads
accordingly to manufacturer instructions (Miltenyi). Cell purity for
FOXP3 was .90%. For CD4+ FOXP3+ Treg adoptive transfer
experiments, CD4+ FOXP3GFP+ cells were FACS sorted from
Foxp3-GFP mice (Jackson Laboratory) on a FACSAria cell sorter
(BD Biosciences). Cell purity for FOXP3 was .99%.
FACS analysis
Extracellular staining was preceded by incubation with purified
anti-CD16/32 antibodies (FcgRII/III block, 2.4G2) (eBioscience)
to block nonspecific staining. Cells were stained with FITC-, PE-,
PECy5-, PECy7-APC- APCAlexa750- or APC-H7-labeled or
biotinylated appropriate antibodies including: CD4 (GK1.5);
TCRb (H57-597); CD25 (PC61.5) or appropriate isotype Abs.
Streptavidin-FITC, PECy5 or PECy7 were used to develop
biotinylated Abs. All Abs were purchased from eBioscience except
APC-H7-labeled antibodies (BD Bioscience). Intranuclear FOXP3
staining was performed using eBioscience PE- or APC conjugated
FOXP3 staining buffer set (FJK-16s). Intracellular Ki-67 staining
was performed using BD Pharmingen Ki-67 (B56) on permeabi-
lized cells. Six-color flow cytometry was performed with a
FACSCanto cytometer (BD Biosciences) and data files were
analyzed using FlowJo software (Tree star Inc).
CFSE labelling
When required, cell division of transferred T cells was assessed
by CFSE labelling (Sigma) using standard methods. Cells were
resuspended in PBS in a concentration of 10
7/mL and incubated
with CFSE at final concentration of 5 mM for 10 min at 37uC,
followed by two washes in ice cold HBSS containing 10% FCS.
Cytokines
Recombinant murine IL-7 (rmIL-7) was purchased from
Immunotools and anti-IL-7 mAb M25 was purchased from
BioXcell. Before injection, cytokines/antibody complexes were
generated as previously described [25]. Briefly, 1 mg of cytokine
was co-incubated with 5 mg of the specific monoclonal antibodies
for 30 min at +37uC. Mice were i.p. injected with PBS or IL-7/
anti-IL-7 complexes (1 mg rmIL-7 plus 5 mg M25) three times at 2
day intervals.
Adoptive transfer experiments
For adoptive transfer experiments into wild type mice, total
CD4 T cells (7.5610
6) from CD45.1 mice were transferred into
CD45.2 C57Bl/6 hosts. Mice were then treated with IL-7/anti-IL-
7 complexes as described. For adoptive transfer experiments into
empty mice, purified CD4+ CD25+ cells (1610
6) or CD4+
FOXP3GFP+ cells (5610
5) were injected into Rag-deficient mice
(Rag2/2) or Rag2/2 mice that were also deficient for IL-7
(Rag2/2 IL-72/2). One and/or six to eight days after transfer,
spleens were harvested and analyzed.
Statistical analyses
Statistical analyses were performed using unpaired Student T
test with Graph Pad Software.
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